Publications for Emelie Djerf
Co-author map based on ISI articles 2007-
Journal Articles
Emelie Djerf, Cecilia Trinks, Henrik Green, Avni Abdiu, Anna-Lotta Hallbeck, Olle Stål and Thomas Walz
The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo
Biochemical and Biophysical Research Communications - BBRC, 2011, 414(3), 563-568.
|
Cecilia Trinks, Emelie A. Severinsson, Birgitta Holmlund, Anna Gréen, Henrik Green, Jan-Ingvar Jönsson, Anna-Lotta Hallbeck and Thomas Walz
The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells
Biochemical and Biophysical Research Communications - BBRC, 2011, 410(3), 422-427.
Web of Science® Times Cited: 1 |
Cecilia Trinks, Emelie Djerf, Anna-Lotta Hallbeck, Jan-Ingvar Jönsson and Thomas Walz
The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393(1), 6-10.
Web of Science® Times Cited: 6 |
Emelie Djerf, Cecilia Trinks, Avni Abdiu, Lena Thunell, Anna-Lotta Hallbeck and Thomas M Walz
ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
Melanoma research, 2009, 19(3), 156-166.
Web of Science® Times Cited: 16 |
Ph.D. Theses
Licentiate Theses
Ph.D., Lic. Theses
